Related Experiment Video
Updated: Jul 2, 2026

Alveolar Macrophage Phagocytosis and Bacteria Clearance in Mice
Published on: March 2, 2019
A role of macrophage complement receptor CRIg in immune clearance and inflammation
Jeannie Q He1, Christian Wiesmann, Menno van Lookeren Campagne
1Department of Immunology, Genentech Inc., South San Francisco, CA 94080, USA.
Insights
Complement receptor of the immunoglobulin superfamily (CRIg) aids in clearing pathogens and cells. Its unique function also allows for selective inhibition of the alternative complement pathway, offering therapeutic potential.
Area of Science:
- Immunology
- Complement System Biology
Background:
- Complement receptor of the immunoglobulin superfamily (CRIg), also known as Z39Ig or VSIG4, is expressed on macrophages.
- CRIg mediates the clearance of pathogens and cellular debris by binding C3b and iC3b.
- The extracellular domain of CRIg can inhibit the alternative complement pathway.
Purpose of the Study:
- To review the multifaceted roles of CRIg in immune functions.
- To explore CRIg's implications in T-cell responses and complement regulation.
- To discuss the potential of CRIg as a therapeutic target for diseases.
Main Methods:
- Literature review of studies on CRIg function.
- Analysis of CRIg's binding properties to complement components.
- Evaluation of CRIg's impact on complement pathways and immune responses.
Main Results:
- CRIg is crucial for the clearance of systemic pathogens and autologous cells by macrophages.
- CRIg binds to C3b and iC3b on particle surfaces, facilitating their removal.
- CRIg's extracellular domain selectively inhibits the alternative complement pathway without affecting the classical pathway.
Conclusions:
- CRIg plays a significant role in immune clearance and complement regulation.
- CRIg's ability to inhibit the alternative complement pathway offers a novel strategy for in vivo blockade.
- Understanding CRIg's functions provides insights into disease mechanisms and potential therapeutic interventions.
Abstract:
Complement receptor of the immunoglobulin superfamily (CRIg), also referred to as Z39Ig and V-set and Ig domain-containing 4 (VSIG4), has recently been implicated in the clearance of systemic pathogens and autologous cells. CRIg is exclusively expressed on tissue resident macrophages and binds to multimers of C3b and iC3b that are covalently attached to particle surfaces. Next to functioning as an important clearance receptor, CRIg's extracellular domain inhibits complement activation through the alternative, but not the classical, pathway, providing a novel tool to selectively block this pathway in vivo. Here, we review a role for CRIg in immune clearance, T-cell responses and complement regulation, and discuss the implications for disease manifestation.
Related Concept Videos
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Complement System
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation
Acute Inflammation II: Cellular Phase
Cell-mediated Immune Responses
